Now Fostera^TM PCV offers flexible dosing to help prevent PCV2 viremia

Now offering a high standard in protocol flexibility, Fostera™ PCV is the only PCV vaccine that can be incorporated into vaccination programs using either two doses or one to help prevent Porcine Circovirus Type 2 (PCV2) viremia and help control lymphoid depletion.

"This flexible dosing claim is another example of our commitment to veterinarian and producer customers and our desire to provide them with options for handling protocols that vary from farm to farm," says Darrell Neuberger, DVM, pork technical services veterinarian for Pfizer Animal Health.

Any amount of PCV2 viremia may negatively impact production, so the goal of vaccination is to create an environment with the least amount of virus present. A study demonstrated that vaccination of pigs with two doses of Fostera PCV compared to non-vaccinated pigs helped prevent PCV2 viremia and helped provide protection against PCV2 infection in lymphatic tissues¹:

• Reduced viremia by up to 8,000 times post-challenge, resulting in a total of 96.8 percent viremia-free days while in study
• All lymphatic tissues in vaccinated pigs were negative for PCV2 infection

"Whether you decide to administer two doses or one of Fostera PCV, both options effectively offer a high standard of consistent performance to help protect pigs against this performance-robbing disease," says Neuberger.

Fostera PCV, which will have a new look featuring a large PCV mark in the upcoming months, can be administered in two ways:

• Two 1-mL doses 3 weeks apart starting at 3 weeks of age or older
• One 2-mL dose at 3 weeks of age or older